ATRESMED.C.D.M.D.C.EO-,75ATRESMED.C.D.M.D.C.EO-,75ATRESMED.C.D.M.D.C.EO-,75

ATRESMED.C.D.M.D.C.EO-,75

No trades
See on Supercharts

YT2A fundamentals

An in-depth look to ATRESMED.C.D.M.D.C.EO-,75 operating, investing, and financing activities

YT2A free cash flow for H2 23 is 114.38 M EUR. For 2023, YT2A free cash flow was 133.9 M EUR and operating cash flow was 163.68 M EUR.

Q1 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q1 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Free cash flowYoY growth